Quick Answer
Sagimet Biosciences Inc. reported Revenue (ASC 606) of $2.00 million for fiscal year 2023.
Sagimet Biosciences Inc. Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2023 | $2.00M | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| September 30, 2023 | $2.00M | — | +0.0% |
| July 31, 2023 | $2.00M | — | — |
- The most recent figure is from Sagimet Biosciences Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 12, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: